Involvement of the opioid and cannabinoid systems in pain control: New insights from knockout studies

Textbook of Medical Physiology

Guyton, A. C., & Hall, J. E. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1363_2 · Cited by 9,760 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,612 · see citing works

Classification of chronic pain

Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 2,952 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · see citing works

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene

Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722 · see citing works

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Marzo, V. D., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,610 · see citing works

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Brain monoglyceride lipase participating in endocannabinoid inactivation

Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · see citing works

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310 · see citing works

A potent and selective endogenous agonist for the µ-opiate receptor

Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,309 · see citing works

Textbook of Medical Physiology

Iatridis, P. G. (1991) · JAMA · doi:10.1001/jama.1991.03470200123049 · Cited by 1,287 · see citing works

Endocannabinoid Signaling in the Brain

Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260 · see citing works

Glial activation: a driving force for pathological pain

Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01854-3 · Cited by 1,091 · see citing works

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,065 · see citing works

Control of pain initiation by endogenous cannabinoids

Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,055 · see citing works

Neurotransmitters in Nociceptive Modulatory Circuits

Fields, H. L., Heinricher, M. M., & Mason, P. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.001251 · Cited by 992 · see citing works

State-dependent opioid control of pain

Fields, H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1431 · Cited by 946 · see citing works

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain

Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820 · see citing works

Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy

Vasudeva, R., Tanga, F. Y., & DeLeo, J. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052407 · Cited by 797 · see citing works

Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ glia

Tsuda, M., Inoue, K., & Salter, M. W. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.12.002 · Cited by 795 · see citing works

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 710 · see citing works

Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses

Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672 · see citing works

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

Schlosburg, J. E., Blankman, J. L., Long, J. Z., Nomura, D. K., Pan, B., Kinsey, S. G., Nguyen, P. T., Ramesh, D., Booker, L., Burston, J. J., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2616 · Cited by 641 · see citing works

Exploring the opioid system by gene knockout

Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620 · see citing works

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1916 · Cited by 571 · see citing works

Peripheral Mechanisms of Opioid Analgesia

Stein, C. (1993) · Anesthesia & Analgesia · doi:10.1213/00000539-199301000-00031 · Cited by 548 · see citing works

Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia

Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R. S., Donovan, D. M., Miner, L. L., & Uhl, G. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1544 · Cited by 525 · see citing works

CB ₂ cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521 · see citing works

Activation of CB ₂ cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491 · see citing works

Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin

König, M., Zimmer, A. M., Steiner, H., Holmes, P. V., Crawley, J. N., Brownstein, M., & Zimmer, A. (1996) · Nature · doi:10.1038/383535a0 · Cited by 486 · see citing works

The endogenous cannabinoid system protects against colonic inflammation

Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B. F., Ferri, G., Sibaev, A., Storr, M., & Lutz, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19465 · Cited by 461 · see citing works

Rapid Signaling of Estrogen in Hypothalamic Neurons Involves a Novel G-Protein-Coupled Estrogen Receptor that Activates Protein Kinase C

Qiu, J., Bosch, M. A., Tobias, S. C., Grandy, D. K., Scanlan, T. S., Rønnekleiv, O. K., & Kelly, M. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-29-09529.2003 · Cited by 460 · see citing works

Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

Ahn, K., Johnson, D. S., Mileni, M., Beidler, D., Long, J. Z., McKinney, M. K., Weerapana, E., Sadagopan, N., Liimatta, M., Smith, S. E., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.02.013 · Cited by 439 · see citing works

Retention of Supraspinal Delta-like Analgesia and Loss of Morphine Tolerance in δ Opioid Receptor Knockout Mice

Zhu, Y., King, M. A., Schuller, A. G., Nitsche, J. F., Reidl, M., Elde, R. P., Unterwald, E. M., Pasternak, G. W., & Pintar, J. E. (1999) · Neuron · doi:10.1016/s0896-6273(00)80836-3 · Cited by 430 · see citing works

Disruption of the κ‐opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ‐agonist U‐50,488H and attenuates morphine withdrawal

Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., & Kieffer, B. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.886 · Cited by 418 · see citing works

An analgesia circuit activated by cannabinoids

Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L. (1998) · Nature · doi:10.1038/26481 · Cited by 411 · see citing works

Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

Marzo, V. D., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 389 · see citing works

The endogenous cannabinoid system protects against colonic inflammation

Massa, F., Marsicano, G., Hermann, H., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419465 · Cited by 387 · see citing works

Immunohistochemical localization of the cloned μ opioid receptor in the rat CNS

Mansour, A., Fox, C. A., Burke, S., Akil, H., & Watson, S. J. (1995) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(95)00055-c · Cited by 370 · see citing works

In silico patent searching reveals a new cannabinoid receptor

Baker, D., Pryce, G., Davies, W. I. L., & Hiley, C. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 347 · see citing works

μ Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality

Loh, H. H., Liu, H.-C., Cavalli, A., Yang, W., Chen, Y.-F., & Wei, L. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00353-7 · Cited by 336 · see citing works

Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain

Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330 · see citing works

Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis.

Rubinstein, M., Mogil, J. S., Japón, M. Á., Chan, E., Allen, R. G., & Low, M. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3995 · Cited by 328 · see citing works

Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain.

Watkins, L. R., Milligan, E. D., & Maier, S. F. (2003) · PubMed · Cited by 314 · see citing works

Retention of heroin and morphine–6β–glucuronide analgesia in a new line of mice lacking exon 1 of MOR–1

Schuller, A. G., King, M. A., Zhang, J., Bolan, E. A., Pan, Y., Morgan, D. J., Chang, A., Czick, M. E., Unterwald, E. M., Pasternak, G. W., et al. (1999) · Nature Neuroscience · doi:10.1038/5706 · Cited by 308 · see citing works

Pronociceptive actions of dynorphin maintain chronic neuropathic pain

Wang, Z., Gardell, L. R., Ossipov, M. H., Vanderah, T. W., Brennan, M. B., Hochgeschwender, U., Hruby, V. J., Malan, T. P., Lai, J., & Porreca, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01779.2001 · Cited by 301 · see citing works

Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study

Hohmann, A. G., & Herkenham, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00524-7 · Cited by 301 · see citing works

Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia

Lichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004) · Pain · doi:10.1016/j.pain.2004.01.022 · Cited by 301 · see citing works

Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids

Liu, X., Liu, Z., Sun, Y.-G., Ross, M. H., Kim, S., Tsai, F.-F., Li, Q., Jeffry, J. A., Kim, J.-Y., Loh, H. H., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.043 · Cited by 289 · see citing works

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Valenzano, K. J., Tafesse, L., Lee, G., Harrison, J. E., Boulet, J. M., Gottshall, S. L., Mark, L., Pearson, M. S., Miller, W., Shan, S., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.008 · Cited by 288 · see citing works

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

Jayamanne, A., Greenwood, R., Mitchell, V. A., Aslan, S., Piomelli, D., & Vaughan, C. W. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706510 · Cited by 287 · see citing works

Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking

Devi, L. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01799-5 · Cited by 282 · see citing works

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

Staton, P. C., Hatcher, J. P., Walker, D. J., Morrison, A. D., Shapland, E. M., Hughes, J. P., Chong, E., Mander, P. K., Green, P. J., Billinton, A., et al. (2008) · Pain · doi:10.1016/j.pain.2008.04.006 · Cited by 270 · see citing works

Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors

Ghozland, S. G., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263 · see citing works

Actions of Cannabinoids on Membrane Properties and Synaptic Transmission in Rat Periaqueductal Gray Neurons In Vitro

Vaughan, C. W., Connor, M. A., Bagley, E. E., & Christie, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23200-4 · Cited by 241 · see citing works

Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice

Monory, K., Blaudzun, H., Massa, F., Kaiser, N., Lemberger, T., Schütz, G., Wotjak, C. T., Lutz, B., & Marsicano, G. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050269 · Cited by 241 · see citing works

Functional disassociation of the central and peripheral fatty acid amide signaling systems

Cravatt, B. F., Saghatelian, A., Hawkins, E. G., Clement, A. B., Bracey, M. H., & Lichtman, A. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401292101 · Cited by 225 · see citing works

The endogenous cannabinoid system and its role in nociceptive behavior

Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203 · see citing works

Activity of the δ-Opioid Receptor Is Partially Reduced, Whereas Activity of the κ-Receptor Is Maintained in Mice Lacking the μ-Receptor

Matthes, H. W. D., Smadja, C., Valverde, O., Vonesch, J., Foutz, A. S., Boudinot, É., Denavit‐Saubié, M., Severini, C., Negri, L., Roques, B. P., et al. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07285.1998 · Cited by 199 · see citing works

Crucial Role of CB₂Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

Racz, I., Nadal, X., Alferink, J., Baños, J. E., Rehnelt, J., Martín, M., Pintado, B., Gutierrez-Adan, A., Sanguino, E., Manzanares, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3400-08.2008 · Cited by 195 · see citing works

Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain

Roques, B. P., Fournié‐Zaluski, M., & Wurm, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3673 · Cited by 193 · see citing works

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

Conti, S., Costa, B., Colleoni, M., Parolaro, D., & Giagnoni, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704466 · Cited by 189 · see citing works

Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase

Clement, A. B., Hawkins, E. G., Lichtman, A. H., & Cravatt, B. F. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03916.2003 · Cited by 187 · see citing works

The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice

Russo, R., LoVerme, J., La Rana, G., Compton, T. R., Parrott, J., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Calignano, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119941 · Cited by 182 · see citing works

Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia

Richardson, J. D., Aanonsen, L., & Hargreaves, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00451.1998 · Cited by 182 · see citing works

Opioid receptors: From binding sites to visible molecules in vivo

Kieffer, B. L., & Evans, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.033 · Cited by 181 · see citing works

Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry

Bridges, D., Rice, A. S. C., Egertová, M., Elphick, M. R., Winter, J., & Michael, G. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00200-8 · Cited by 173 · see citing works

CB2 cannabinoid receptor mediation of antinociception

Ibrahim, M. M., Rude, M. L., Stagg, N. J., Mata, H. P., Lai, J. Y., Vanderah, T. W., Porreca, F., Buckley, N. E., Makriyannis, A., & Malan, P. T. (2006) · Pain · doi:10.1016/j.pain.2005.12.018 · Cited by 172 · see citing works

Altered Hematopoiesis, Behavior, and Sexual Function in μ Opioid Receptor–deficient Mice

Tian, M., Broxmeyer, H. E., Fan, Y., Lai, Z., Zhang, S., Aronica, S. M., Cooper, S. H., Bigsby, R. M., Steinmetz, R. W., Engle, S. J., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1517 · Cited by 172 · see citing works

Neutral endopeptidase modulation of septic shock.

Lu, B., Gerard, N. P., Kolakowski, L. F., Bozza, M. T., Zurakowski, D., Finco, O., Carroll, M. C., & Gerard, C. J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2271 · Cited by 167 · see citing works

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Chang, L., Luo, L., Palmer, J. A., Sutton, S. W., Wilson, S. J., Barbier, A., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706773 · Cited by 166 · see citing works

Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections

Martin, W. J., Coffin, P. O., Attias, E., Balinsky, M., Tsou, K., & Walker, J. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01368-7 · Cited by 164 · see citing works

Resveratrol Engages AMPK to Attenuate ERK and mTOR Signaling in Sensory Neurons and Inhibits Incision-Induced Acute and Chronic Pain

Tillu, D. V., Melemedjian, O. K., Asiedu, M. N., Qu, N., Felice, M. D., Dussor, G. O., & Price, T. J. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-5 · Cited by 163 · see citing works

Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia

Gavériaux‐Ruff, C., Nozaki, C., Nadal, X., Hever, X. C., Weibel, R., Matifas, A., Reiss, D. J., Filliol, D., Nassar, M. A., Wood, J. N., et al. (2011) · Pain · doi:10.1016/j.pain.2010.12.031 · Cited by 161 · see citing works

Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives

Hohmann, A. G. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00154-8 · Cited by 159 · see citing works

Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance

Xu, M., Petraschka, M., McLaughlin, J. P., Westenbroek, R. E., Caron, M. G., Lefkowitz, R. J., Czyzyk, T. A., Pintar, J. E., Terman, G. W., & Chavkin, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5552-03.2004 · Cited by 156 · see citing works

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706699 · Cited by 155 · see citing works

Female preproenkephalin-knockout mice display altered emotional responses

Ragnauth, A. K., Schuller, A. G., Morgan, M. A., Chan, J. S. W., Ogawa, S., Pintar, J. E., Bodnar, R. J., & Pfaff, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1958 · Cited by 150 · see citing works

Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance

Ossipov, M. H., Lai, J. Y., Vanderah, T. W., & Porreca, F. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00410-7 · Cited by 146 · see citing works

Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice

Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., & Maldonado, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09499.2001 · Cited by 140 · see citing works

Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla

Martin, W. J., Tsou, K., & Walker, J. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00044-5 · Cited by 138 · see citing works

Interferon-γ Is a Critical Modulator of CB2Cannabinoid Receptor Signaling during Neuropathic Pain

Rácz, I., Nadal, X., Alferink, J., Baños, J.-E., Rehnelt, J., Martín, M., Pintado, B., Gutiérrez‐Adán, A., Sanguino, E., Bellora, N., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3402-08.2008 · Cited by 134 · see citing works

Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors Produce Anti-Allodynic Effects in Mice Through Distinct Cannabinoid Receptor Mechanisms

Kinsey, S. G., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.04.001 · Cited by 118 · see citing works

The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in mice

Booker, L., Kinsey, S. G., Abdullah, R. A., Blankman, J. L., Long, J. Z., Ezzili, C., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01445.x · Cited by 116 · see citing works

Inflammatory pain is enhanced in delta opioid receptor‐knockout mice

Gavériaux‐Ruff, C., Karchewski, L. A., Hever, X. C., Matifas, A., & Kieffer, B. L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06223.x · Cited by 116 · see citing works

Neuropathic pain is enhanced in δ‐opioid receptor knockout mice

Nadal, X., Baños, J.-E., Kieffer, B. L., & Maldonado, R. J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04569.x · Cited by 115 · see citing works

Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception

Naidu, P. S., Booker, L., Cravatt, B. F., & Lichtman, A. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143487 · Cited by 114 · see citing works

1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice

Luongo, L., Palazzo, E., Tambaro, S., Giordano, C. S. D. S., Gatta, L., Scafuro, M. A., Rossi, F., Lazzari, P., Pani, L., de Novellis, V., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.021 · Cited by 113 · see citing works

Reduction of stress‐induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

Valverde, O., Ledent, C. A., Beslot, F., Parmentier, M., & Roques, B. P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00929.x · Cited by 111 · see citing works

Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice

Valverde, O., Maldonado, R. J., Valjent, E., Zimmer, A. M., & Zimmer, A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09284.2000 · Cited by 110 · see citing works

Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones

Martín, M., Matifas, A., Maldonado, R. J., & Kieffer, B. L. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02482.x · Cited by 110 · see citing works

Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide Hydrolase

Naidu, P. S., Kinsey, S. G., Guo, T. L., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164806 · Cited by 108 · see citing works

Pain and the immune system

Rittner, H. L., Brack, A., & Stein, C. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen078 · Cited by 102 · see citing works

A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain

Yu, X. H., Cao, C. Q., Martino, G., Puma, C., Morinville, A., St-Onge, S., Lessard, É., Perkins, M., & Laird, J. M. A. (2010) · Pain · doi:10.1016/j.pain.2010.07.019 · Cited by 99 · see citing works

Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia

Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 96 · see citing works

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833

Whiteside, G. T., Gottshall, S. L., Boulet, J. M., Chaffer, S. M., Harrison, J., Pearson, M. S., Turchin, P. I., Mark, L., Garrison, A. E., & Valenzano, K. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.043 · Cited by 94 · see citing works

The rodent amygdala contributes to the production of cannabinoid-induced antinociception

Manning, B. H., Martin, W. J., & Meng, I. D. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00356-7 · Cited by 94 · see citing works

Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum

Bian, D., Ossipov, M. H., Ibrahim, M. M., Raffa, R. B., Tallarida, R. J., Malan, T. P., Lai, J. Y., & Porreca, F. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01393-1 · Cited by 91 · see citing works

Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain

Jhaveri, M. D., Sagar, D. R., Elmes, S. J. R., Kendall, D. A., & Chapman, V. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8007-7 · Cited by 89 · see citing works

Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain

Yamamoto, W., Mikami, T., & Iwamura, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.010 · Cited by 89 · see citing works

Stress-induced analgesia and endogenous opioid peptides: The importance of stress duration

Parikh, D., Hamid, A., Friedman, T. C., Nguyen, K. N. T., Tseng, A., Marquez, P. V., & Lutfy, K. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.050 · Cited by 89 · see citing works

CB₁Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents

Brusberg, M., Arvidsson, S., Kang, D., Larsson, H., Lindström, E., & Martinez, V. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5166-08.2009 · Cited by 88 · see citing works

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice

Kinsey, S. G., Naidu, P. S., Cravatt, B. F., Dudley, D. T., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.022 · Cited by 87 · see citing works

Generation of dynorphin knockout mice

Sharifi, N., Diehl, N. L., Yaswen, L. R., Brennan, M. B., & Hochgeschwender, U. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00264-3 · Cited by 85 · see citing works

Constitutive Activity at the Cannabinoid CB 1 Receptor Is Required for Behavioral Response to Noxious Chemical Stimulation of TRPV1: Antinociceptive Actions of CB1 Inverse Agonists

Fioravanti, B., Felice, M. D., Stucky, C. L., Medler, K. A., Luo, M.-C., Gardell, L. R., Ibrahim, M. M., Malan, T. P., Yamamura, H. I., Ossipov, M. H., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3322-08.2008 · Cited by 85 · see citing works

Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice

Zhang, Y., Li, H., Li, Y., Sun, X., Zhu, M., Hanley, G., LeSage, G., & Yin, D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.11.063 · Cited by 82 · see citing works

Activation of spinal cannabinoid 1 receptors inhibits C‐fibre driven hyperexcitable neuronal responses and increases [35S]GTPγS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats

Drew, L., Harris, J. E., Millns, P. J., Kendall, D. A., & Chapman, V. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00101.x · Cited by 82 · see citing works

The μ‐opioid receptor agonist morphine, but not agonists at δ‐ or κ‐opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors

Da Fonseca Pacheco, D., Klein, A., De Castro Perez, A., Da Fonseca Pacheco, C. M., De Francischi, J. N., & Duarte, I. D. G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.175 · Cited by 81 · see citing works

Dissociation of Analgesic and Hormonal Responses to Forced Swim Stress Using Opioid Receptor Knockout Mice

Contet, C., Gavériaux‐Ruff, C., Matifas, A., Caradec, C., Champy, M., & Kieffer, B. L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300934 · Cited by 81 · see citing works

The Roles of Streptozotocin Neurotoxicity and Neutral Endopeptidase in Murine Experimental Diabetic Neuropathy

Davidson, E. P., Coppey, L. J., Lu, B., Arballo, V., Calcutt, N. A., Gerard, C. J., & Yorek, M. A. (2009) · Experimental Diabetes Research · doi:10.1155/2009/431980 · Cited by 81 · see citing works

δ-Opioid Mechanisms for ADL5747 and ADL5859 Effects in Mice: Analgesia, Locomotion, and Receptor Internalization

Nozaki, C., Bourdonnec, B. L., Reiss, D. J., Windh, R. T., Little, P., Dolle, R. E., Kieffer, B. L., & Gavériaux‐Ruff, C. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188987 · Cited by 79 · see citing works

Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate

La Porta, C., Bura, S. A., Aracil-Fernández, A., Manzanares, J., & Maldonado, R. (2013) · Pain · doi:10.1016/j.pain.2012.10.009 · Cited by 75 · see citing works

Analysis of [3H] bremazocine binding in single and combinatorial opioid receptor knockout mice

Simonin, F., Slowe, S. J., Becker, J. A. J., Matthes, H. W. D., Filliol, D., Chluba, J., Kitchen, I., & Kieffer, B. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00822-6 · Cited by 72 · see citing works

Enhanced δ-opioid receptor-mediated antinociception in μ-opioid receptor-deficient mice

Qiu, C., Sora, I., Ren, K., Uhl, G. R., & Dubner, R. A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00813-4 · Cited by 72 · see citing works

Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds

Bilkei‐Gorzó, A., Rácz, I., Michel, K., Zimmer, A. M., Klingm�ller, D., & Zimmer, A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1904-9 · Cited by 71 · see citing works

Cannabinoid inhibition of the capsaicin‐induced calcium response in rat dorsal root ganglion neurones

Millns, P. J., Chapman, V., & Kendall, D. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703919 · Cited by 71 · see citing works

Mechanisms of Induction of Persistent Nociception by Dynorphin

Laughlin, T. M., Larson, A. A., & Wilcox, G. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29295-8 · Cited by 71 · see citing works

Essential role of mu opioid receptor in the regulation of delta opioid receptor–mediated antihyperalgesia

Gendron, L., Pintar, J. E., & Chavkin, C. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.060 · Cited by 69 · see citing works

Central antinociception induced by µ‐opioid receptor agonist morphine, but not δ‐ or κ‐, is mediated by cannabinoid CB1receptor

Pacheco, D. D. F., Klein, A., Perez, A. C., Pacheco, C. M. D. F., Francischi, J. N., Reis, G. M. L., & Duarte, I. D. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00310.x · Cited by 68 · see citing works

Spinal inhibitory neurotransmission in neuropathic pain

Taylor, B. K. (2009) · Current Pain and Headache Reports · doi:10.1007/s11916-009-0035-8 · Cited by 67 · see citing works

Characterization of mechanical withdrawal responses and effects of μ-, δ- and κ-opioid agonists in normal and μ-opioid receptor knockout mice

Fuchs, P. N., Roza, C., Sora, I., Uhl, G. R., & Raja, S. N. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01060-4 · Cited by 67 · see citing works

Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice

Castañé, A., Robledo, P., Matifas, A., Kieffer, B. L., & Maldonado, R. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02409.x · Cited by 67 · see citing works

The absence of endogenous β-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation

Petraschka, M., Li, S., Gilbert, T. L., Westenbroek, R. E., Bruchas, M. R., Schreiber, S., Lowe, J. A., III, Low, M. J., Pintar, J. E., & Chavkin, C. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.029 · Cited by 63 · see citing works

Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses

Maldonado, R. J., & Valverde, O. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.001 · Cited by 62 · see citing works

Visceral chemical nociception in mice lacking μ-opioid receptors: effects of morphine, SNC80 and U-50,488

Sora, I., Li, X.-F., Funada, M., Kinsey, S., & Uhl, G. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00933-9 · Cited by 61 · see citing works

δ-Opioid receptor agonists produce antinociception and [35S]GTPγS binding in μ receptor knockout mice

Hosohata, Y., Vanderah, T. W., Burkey, T. H., Ossipov, M. H., Kovelowski, C. J., Sora, I., Uhl, G. R., Zhang, X., Rice, K. C., Roeske, W. R., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00897-3 · Cited by 60 · see citing works

The μ-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in μ-opioid receptor knockout mice

Mizoguchi, H., Narita, M., Oji, D. E., Suganuma, C., Nagase, H., Sora, I., Uhl, G. R., Cheng, E. Y., & Tseng, L. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00298-5 · Cited by 58 · see citing works

Lack of effect of chronic pre‐treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system

Okine, B. N., Norris, L. M., Woodhams, S. G., Burston, J. J., Patel, A., Alexander, S. P. H., Barrett, D. A., Kendall, D. A., Bennett, A. J., & Chapman, V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02028.x · Cited by 56 · see citing works

Opioid-related changes in nociceptive threshold and in tissue levels of enkephalins after target disruption of the gene for neutral endopeptidase (EC 3.4.24.11) in mice

Saria, A., Hauser, K. F., Traurig, H. H., Turbek, C. S., Hersh, L. B., & Gerard, C. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00660-5 · Cited by 52 · see citing works

Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(−/−) and not CB2(−/−) mice in models of acute and persistent pain

Sain, N. M. H., Liang, A., Kane, S. A., & Urban, M. O. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.004 · Cited by 51 · see citing works

Molecular and Neuroanatomical Properties of the Endogenous Opioid System: Implications for Treatment of Opiate Addiction

Akil, H., Meng, F., Devine, D. P., & Watson, S. J. (1997) · Seminars in Neuroscience · doi:10.1006/smns.1997.0108 · Cited by 48 · see citing works

Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain

Pol, O., Murtra, P., Caracuel, L., Valverde, O., Puig, M. M., & Maldonado, R. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.002 · Cited by 47 · see citing works

No heroin or morphine 6β-glucuronide analgesia in μ-opioid receptor knockout mice

Kitanaka, N., Sora, I., Kinsey, S., Zeng, Z., & Uhl, G. R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00516-0 · Cited by 46 · see citing works

Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice

Hough, L. B., Nalwalk, J. W., Chen, Y., Schuller, A. G., Zhu, Y., Zhang, J., Menge, W. M. P. B., Leurs, R., Timmerman, H., & Pintar, J. E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02776-1 · Cited by 46 · see citing works

Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase

Haller, V. L., Stevens, D. L., & Welch, S. P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.005 · Cited by 45 · see citing works

Stress-induced analgesia in μ-opioid receptor knockout mice reveals normal function of the δ-opioid receptor system

LaBuda, C. J., Sora, I., Uhl, G. R., & Fuchs, P. N. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02196-x · Cited by 45 · see citing works

Comparison of opioid receptor distributions in the rat central nervous system

Gray, A. C., Coupar, I. M., & White, P. J. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.021 · Cited by 45 · see citing works

Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase

Krämer, H. H., He, L., Lu, B., Birklein, F., & Sommer, C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.002 · Cited by 42 · see citing works

Development and expression of neuropathic pain in CB1 knockout mice

Castañé, A., Célèrier, E., Martín, M., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.022 · Cited by 42 · see citing works

Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain

Rothman, R. B., Brady, L. S., Xu, H., & Long, J. B. (1993) · Peptides · doi:10.1016/0196-9781(93)90187-l · Cited by 41 · see citing works

Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors

Wise, L. E., Shelton, C. C., Cravatt, B. F., Martin, B. R., & Lichtman, A. H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.002 · Cited by 40 · see citing works

CB2 cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: Role of CB2 receptor in pain

Páldy, E., Bereczki, E., Sántha, M., Wenger, T., Borsodi, A. D., Zimmer, A., & Benyhe, S. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.08.005 · Cited by 40 · see citing works

Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain

Leichsenring, A., Andriske, M., Bäcker, I., Stichel, C. C., & Lübbert, H. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0386-4 · Cited by 39 · see citing works

Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation

Schepers, R. J., Mahoney, J. L., Gehrke, B. J., & Shippenberg, T. S. (2008) · Pain · doi:10.1016/j.pain.2008.01.023 · Cited by 37 · see citing works

Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice

Miller, L. L., Picker, M. J., Schmidt, K. T., & Dykstra, L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2232-5 · Cited by 35 · see citing works

‘Knock-down’ of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice

Dogrul, A. B., Gardell, L. R., Ma, S.-W., Ossipov, M. H., Porreca, F., & Lai, J. Y. (2002) · Pain · doi:10.1016/s0304-3959(02)00302-0 · Cited by 34 · see citing works

The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout mice

Kögel, B. Y., Vry, J. D., Tzschentke, T., & Christoph, T. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.014 · Cited by 32 · see citing works

DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice

Guo, X.-H., Fairbanks, C. A., Stone, L. S., & Loh, H. H. (2003) · Pain · doi:10.1016/s0304-3959(03)00007-1 · Cited by 29 · see citing works

Neutral Endopeptidase Knockout Induces Hyperalgesia in a Model of Visceral Pain, an Effect Related to Bradykinin and Nitric Oxide

Fischer, H. S., Zernig, G., Hauser, K. F., Gerard, C. J., Hersh, L. B., & Saria, A. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:129 · Cited by 28 · see citing works

Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state

Narita, M., Imai, S., Nakamura, A., Ozeki, A., Asato, M., Rahmadi, M., Sudo, Y., Hojo, M., Uezono, Y., Devi, L. A., et al. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00354.x · Cited by 27 · see citing works

Differential Regulation of Morphine Antinociceptive Effects by Endogenous Enkephalinergic System in the Forebrain of Mice

Chen, J. T.-C., Cheng, Y., Sun, W., & Shyu, B. (2008) · Molecular Pain · doi:10.1186/1744-8069-4-41 · Cited by 24 · see citing works

Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in μ-opioid receptor knockout mice

Ide, S., Minami, M., Ishihara, K., Uhl, G. R., Satoh, M., Sora, I., & Ikeda, K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.008 · Cited by 23 · see citing works

Topographic organization in the retinocollicular pathway of the fetal cat demonstrated by retrograde labeling of ganglion cells

Chalupa, L. M., Snider, C. J., & Kirby, M. A. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960429)368:2 · Cited by 22 · see citing works

(−)-Pentazocine Induces Visceral Chemical Antinociception, but not Thermal, Mechanical, or Somatic Chemical Antinociception, in μ-Opioid Receptor Knockout Mice

Ide, S., Minami, M., Uhl, G. R., Satoh, M., Sora, I., & Ikeda, K. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-23 · Cited by 21 · see citing works

Behavioral Effects of Pulp Exposure in Mice Lacking Cannabinoid Receptor 2

Flake, N., & Zweifel, L. S. (2011) · Journal of Endodontics · doi:10.1016/j.joen.2011.09.015 · Cited by 20 · see citing works

Dynorphin-independent spinal cannabinoid antinociception

Gardell, L. R., Ossipov, M. H., Vanderah, T. W., Lai, J., & Porreca, F. (2002) · Pain · doi:10.1016/s0304-3959(02)00173-2 · Cited by 17 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

The Role of the Endocannabinoid System in Pain

Woodhams, S. G., Sagar, D. R., Burston, J. J., & Chapman, V. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_7 · Cited by 205 · see citing works

Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies

Befort, K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00006 · Cited by 134 · see citing works

The endocannabinoid system and neuropathic pain

Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2015) · Pain · doi:10.1097/j.pain.0000000000000428 · Cited by 128 · see citing works

The Role of Descending Modulation in Manual Therapy and Its Analgesic Implications: A Narrative Review

Vigotsky, A. D., & Bruhns, R. P. (2015) · Pain Research and Treatment · doi:10.1155/2015/292805 · Cited by 114 · see citing works

The Endocannabinoid System and Physical Exercise

Matei, D., Trofin, D., Iordan, D. A., Onu, I., Condurache, I., Ionițe, C., & Buculei, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031989 · Cited by 118 · see citing works

Medical Cannabis for Neuropathic Pain

Lee, G., Grovey, B., Furnish, T. J., & Wallace, M. S. (2018) · Current Pain and Headache Reports · doi:10.1007/s11916-018-0658-8 · Cited by 87 · see citing works

Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures

Sugaya, Y., Yamazaki, M., Uchigashima, M., Kobayashi, K., Watanabe, M., Sakimura, K., & Kano, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.083 · Cited by 81 · see citing works

Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?

Maccarrone, M., Maldonado, R. J., Casas, M., Henze, T., & Centonze, D. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1292849 · Cited by 79 · see citing works

Zebrafish models relevant to studying central opioid and endocannabinoid systems

Demin, K. A., Мешалкина, Д. А., Kysil, E. V., Antonova, K. A., Volgin, A. D., Yakovlev, O. A., Alekseeva, P. A., Firuleva, M. M., Lakstygal, A. M., de Abreu, M. S., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.024 · Cited by 64 · see citing works

Subcellular specificity of cannabinoid effects in striatonigral circuits

Gómez, E. S., Zottola, A. C. P., Mariani, Y., Desprez, T., Barresi, M., Río, I. B., Muguruza, C., Bon-Jégo, M. L., Julio‐Kalajzić, F., Flynn, R. E., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.03.007 · Cited by 64 · see citing works

Expression of Opioid Receptors in Cells of the Immune System

Brejchová, J., Holáň, V., & Svoboda, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010315 · Cited by 56 · see citing works

In vivoopioid receptor heteromerization: where do we stand?

Massotte, D. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12702 · Cited by 44 · see citing works

Cannabinoid Receptor Type 1 Antagonist, AM-251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury

Ueda, M., Iwasaki, H., Wang, S.-X., Murata, E., Poon, K. Y. T., Mao, J., & Martyn, J. J. J. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000422 · Cited by 43 · see citing works

Involvement of the dynorphin/KOR system on the nociceptive, emotional and cognitive manifestations of joint pain in mice

Negrete, R., García‐Gutiérrez, M. S., Manzanares, J., & Maldonado, R. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.026 · Cited by 36 · see citing works

Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice

Sakakihara, M., Imamachi, N., & Saito, Y. (2015) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000326 · Cited by 33 · see citing works

Usefulness of knockout mice to clarify the role of the opioid system in chronic pain

Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14088 · Cited by 32 · see citing works

MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling

Chiarlone, A., Börner, C., Martín-Gómez, L., Jiménez-González, A., García-Concejo, A., García‐Bermejo, L., Lorente, M., Blázquez, C., García-Taboada, E., Haro, A., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.007 · Cited by 29 · see citing works

Mu and delta opioid receptor knockout mice show increased colonic sensitivity

Reiss, D., Ceredig, R. A., Secher, T., Boué, J., Barreau, F., Dietrich, G., & Gavériaux-Ruff, C. (2017) · European Journal of Pain · doi:10.1002/ejp.965 · Cited by 20 · see citing works

The role of the endocannabinoid system in the antihyperalgesic effect of Cedrus atlantica essential oil inhalation in a mouse model of postoperative pain

Emer, A. A., Donatello, N. N., Batisti, A. P., Belmonte, L. A. O., Santos, A. R. S., & Martins, D. F. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.09.011 · Cited by 24 · see citing works

Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities

Gaborit, M., & Massotte, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15772 · Cited by 22 · see citing works

Cannabinoids in Health and Disease

Meccariello, R., & Chianese, R. (2016) · InTech eBooks · doi:10.5772/61595 · Cited by 21 · see citing works

Dynamic Measurement of Extracellular Opioid Activity: Status Quo, Challenges, and Significance in Rewarded Behaviors

Murphy, N. P. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500295q · Cited by 18 · see citing works

Delta‐9‐tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation

Wong, H., Hossain, S., & Cairns, B. E. (2017) · European Journal of Pain · doi:10.1002/ejp.1085 · Cited by 18 · see citing works

G Protein-Coupled Receptor Dimerization—What Next?

Dziedzicka‐Wasylewska, M., Polit, A., Błasiak, E., & Faron‐Górecka, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063089 · Cited by 17 · see citing works

The endocannabinoid system as a therapeutic target in neuropathic pain: a review

Quintero, J.-M., Díaz, L. E., Galve‐Roperh, I., Bustos, R., Leon, M.-X., Beltran, S., & Dodd, S. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2407824 · Cited by 18 · see citing works

Kappa opioid receptor modulation of endometriosis pain in mice

Escudero-Lara, A., Cabañero, D., & Maldonado, R. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108677 · Cited by 17 · see citing works

Antinociceptive and Abuse Potential Effects of Cannabinoid/Opioid Combinations in a Chronic Pain Model in Rats

Alsalem, M., Altarifi, A., Haddad, M., Aldossary, S. A., Kalbouneh, H., Aldaoud, N., Saleh, T., & El‐Salem, K. (2019) · Brain Sciences · doi:10.3390/brainsci9110328 · Cited by 16 · see citing works

Endocannabinoids and aging—Inflammation, neuroplasticity, mood and pain

Park, Y., & Watkins, B. A. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.007 · Cited by 16 · see citing works

In vivo neuronal co-expression of mu and delta opioid receptors uncovers new therapeutic perspectives

Erbs, E., Faget, L. C., Veinante, P., Kieffer, B. L., & Massotte, D. (2014) · Receptors & Clinical Investigation · doi:10.14800/rci.210 · Cited by 15 · see citing works

One-step generation of mice carrying a conditional allele together with an HA-tag insertion for the delta opioid receptor

Su, D., Wang, M., Ye, C., Fang, J., Duan, Y., Zhang, Z., Hua, Q., Shi, C., Zhang, L., Zhang, R., et al. (2017) · Scientific Reports · doi:10.1038/srep44476 · Cited by 15 · see citing works

Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy

Micheli, L., Maggini, V., Ciampi, C., Gallo, E. R., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Mannelli, L. D. C., Leo, M. D., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7709 · Cited by 13 · see citing works

Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model

Zhang, R., Xu, B., Zhang, M., Zhang, T., Wang, Z., Zhao, G., Zhao, G., Li, N., Fang, Q., & Wang, R. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.044 · Cited by 12 · see citing works

Knock-In Mouse Models to Investigate the Functions of Opioid Receptors in vivo

Degrandmaison, J., Rochon-Haché, S., Parent, J., & Gendron, L. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.807549 · Cited by 12 · see citing works

Unraveling Chronic Pain: From Mechanisms and Risks to Diagnosis and Treatment

Dai, X., Wang, C., Jiang, P., & Mei, X. (2026) · MedComm · doi:10.1002/mco2.70685 · Cited by 14 · see citing works

Genetic network regulating visual acuity makes limited contribution to visually guided eye emmetropization

Tkatchenko, T. V., & Tkatchenko, A. V. (2021) · Genomics · doi:10.1016/j.ygeno.2021.06.021 · Cited by 10 · see citing works

Mu opioid receptor knockout mouse: Phenotypes with implications on restless legs syndrome

Lyu, S., DeAndrade, M. P., Unger, E. L., Mueller, S., Oksche, A., Walters, A. S., & Li, Y. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24637 · Cited by 10 · see citing works

Mu-opioidergic modulation differs in deep and superficial wide-dynamic range dorsal horn neurons in mice

Xu, Q., Li, W.-Y., & Guan, Y. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.05.059 · Cited by 9 · see citing works

Assessment of Clinical Outcomes in Patients With Osteoarthritis: Analysis From the UK Medical Cannabis Registry

Francis, A., Erridge, S., Holvey, C., Coomber, R., Holden, W., Rucker, J., Platt, M. W., & Sodergren, M. H. (2024) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2024.2340076 · Cited by 9 · see citing works

Cannabis for Chronic Pain: Mechanistic Insights and Therapeutic Challenges

Matos, C. M., Pereira, A. T., Dias, M. J., Sousa, C., Vinha, A. F., Moutinho, C. M. S. G., & Carvalho, M. C. (2025) · Stresses · doi:10.3390/stresses5010007 · Cited by 8 · see citing works

The changing role of descending control of spinal nociception over postnatal development

Battell, E. E., Lillywhite, A., & Hathway, G. J. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.08.003 · Cited by 6 · see citing works

Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats

Zubrzycki, M., Zubrzycka, M., Wysiadecki, G., Szemraj, J., Jerczyńska, H., & Stasiołek, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094665 · Cited by 6 · see citing works

UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co‐morbid sleep impairment

Datta, I., Erridge, S., Holvey, C., Coomber, R., Guru, R., Holden, W., Medniuk, A. D., Sajad, M., Searle, R. D., Usmani, A., et al. (2024) · Pain Practice · doi:10.1111/papr.13438 · Cited by 5 · see citing works

Decoding chronic pain: insights into the transition from acute to persistent pain

Wadhwa, K., Chauhan, P., Singh, G., Jha, S. K., Almutary, A. G., & Jha, N. K. (2025) · Open Biology · doi:10.1098/rsob.240234 · Cited by 5 · see citing works

Clinical epidemiology in complementary medicine (discussion)

Novikov, Y. О., Tsykunov, М. B., & Шаяхметов, А. Р. (2021) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2106-06 · Cited by 5 · see citing works

Dorsal Column Stimulation and Cannabinoids in the Treatment of Chronic Nociceptive and Neuropathic Pain: a Review of the Clinical and Pre-clinical Data

Odonkor, C. A., AlFarra, T., Adekoya, P., Orhurhu, V., Rodríguez, T., Sottosanti, E., & Kaye, A. D. (2022) · Current Pain and Headache Reports · doi:10.1007/s11916-022-01008-y · Cited by 4 · see citing works

CB1 Agonism Alters Addiction-Related Behaviors in Mice Lacking Mu or Delta Opioid Receptors

Roeckel, L.-A., Massotte, D., Olmstead, M. C., & Befort, K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00630 · Cited by 4 · see citing works

Protective effects of anandamide against cisplatin-induced peripheral neuropathy in rats

Ünel, Ç. Ç., Ayaz, B. D., Aydın, Ş., Ulupınar, E., Özatik, O., Kaygısız, B., Yildirim, E. O., & Erol, K. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2101-224 · Cited by 4 · see citing works

Rational design of Gi-biased CB1 agonist with reduced side effects

Liao, Y.-Y., Che, J., Yun-tao, G., Xue, J., Li, L., Wu, L.-L., Hu, J.-X., Hu, M.-T., Xie, L., Zhang, H., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.020 · Cited by 3 · see citing works

How Institutional Quality Causes Financial Development?

Yousaf, H., & Riaz, K. (2024) · The Developing Economies · doi:10.1111/deve.12410 · Cited by 4 · see citing works

Guidelines for the successful management of fibromyalgia patients

Bennett, R. M. (2014) · Indian Journal of Rheumatology · doi:10.1016/j.injr.2014.09.011 · Cited by 3 · see citing works

Cannabinoids: Drug or Medication?

Giron, L., & Befort, K. (2016) · InTech eBooks · doi:10.5772/63172 · Cited by 3 · see citing works

The involvement of ventral hippocampal microglial cells, but not cannabinoid CB1 receptors, in morphine-induced analgesia in rats

Javid, H., Rezayof, A., Ghasemzadeh, Z., & Sardari, M. (2019) · Acta Neurologica Belgica · doi:10.1007/s13760-019-01144-0 · Cited by 3 · see citing works

Targeting G protein coupled receptors for alleviating neuropathic pain

Kumari, P., Yadav, A., Patel, M., & Yadav, P. N. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.004 · Cited by 3 · see citing works

Pain, pleasure and placebo: the cannabinoids in reward processing and the perception of pain

Brodermann, M. H. (2016) · Mental Health and Addiction Research · doi:10.15761/mhar.1000115 · Cited by 3 · see citing works

Cannabis en el tratamiento del dolor crónico no oncológico

Evelyn Muñoz, S. (2015) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2015.71526 · Cited by 3 · see citing works

Interaction between endocannabinoids and the adrenergic system before and after stress-exposure

Nocheva, H., Encheva-Stoykova, E. N., & Grigorov, E. E. (2022) · Pharmacia · doi:10.3897/pharmacia.69.e80550 · Cited by 2 · see citing works

A synergistic analgesic effect of morphine in combination with the CB1 receptor agonist, ACPA, in normal, hypothyroid, and hyperthyroid male rats

Zarrindast, M., & Khakpai, F. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-014 · Cited by 2 · see citing works

Situación actual de Cannabis sativa, beneficios terapéuticos y reacciones adversas

Rodríguez-Venegas, E. D. L. C., & Fontaine-Ortiz, J. E. (2020) · Revista Habanera de Ciencias Médicas · Cited by 2 · see citing works

The Roles of Endogenous Opioids in Placebo and Nocebo Effects: From Pain to Performance to Prozac

Kerr, P. L., & Gregg, J. M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-45493-6_10 · Cited by 1 · see citing works

Cannabinoids and the brain: New hopes for new therapies

Fernández‐Ruíz, J., Hernández, M., & García‐Movellán, Y. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch6 · Cited by 1 · see citing works

LCK connects NTB-A and SAP signaling in T cells to restimulation-induced cell death

Faget, L. C. (2014) · Receptors & Clinical Investigation · doi:10.14800/rci.292

Comparação dos efeitos farmacológicos do canabidiol e seu análogo sintético HU-474

da Silva, N. R. (2017) · doi:10.11606/d.17.2017.tde-20072016-163333

Mina tratatzeko estrategia farmakologiko berriak: kannabinoideak

Aostri, E., Pineda, J., & Mendiguren, A. (2017) · Osagaiz osasun-zientzien aldizkaria · doi:10.26876/osagaiz.2.2017.91

Cannabinoids as a Therapeutic Approach in Multiple Sclerosis

Pryce, G., & Baker, D. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016070-00241

Recrutamento de receptores canabinoides do tipo 1 (CB1) no efeito do canabidiol sobre as respostas defensivas inatas evocadas por camundongos ameaçados por jararacas

Rodrigues, B. M. D. P. (2020) · doi:10.11606/d.59.2020.tde-28112019-164606

Drug Administration Before or After Exposure to Low Temperatures—Does It Matter for the Therapeutic Effect?

Bezirci, K., Borisova, B., Papadakis, K., Danalev, D. L., & Nocheva, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083883

L-Malic acid from Cissus gongylodes induces cannabinoid-mediated antinociception in mice

Calazans, M. O., Pimenta, L. P. S., Romero, T. R. L., Duarte, I. D. G., & Perez, A. C. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121306

Delta opioid receptor expression in various models of chronic clinical conditions

Ceredig, R. A. (2016) · theses.fr (ABES) · doi:10.70675/e750f280zf542z480dz8e6czab49ecd74230

Identification et caractérisation de nouveaux outils pharmacologiques sélectifs pour les différents récepteurs à peptides RF-amides

Quillet, R. (2018) · doi:10.70675/48fb3ad0zf8eez49f2za284zea0ba998a8c5

Le récepteur opioïde Mu et les interactions entre systèmes opioïde et cannabinoïde dans les effets nociceptifs et addictogènes de la morphine

Roeckel, L.-A. (2018) · doi:10.70675/f064a30ezd18fz44f5za9a5z7fd570a696b8

Cannabis-based medicinal products for cancer pain: a two-year prospective analysis from the UK medical cannabis registry

Ukpeh, P., Erridge, S., Clarke, E., McLachlan, K., Coomber, R., Rucker, J., Platt, M. W., Khan, S. A., & Sodergren, M. H. (2026) · Progress in Palliative Care · doi:10.1080/09699260.2026.2650901

Opioids, palatable feeding and exercise

Ugur, M. (2019) · doi:10.70675/96430ef5z0268z4e14za024z45e7fa53eda6

Cannabis

Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7

Novel targets in headache: A narrative review

Pietra, A. D., Goadsby, P. J., Oldoni, C., Silberstein, S. D., Cohen, F., & Akerman, S. (2026) · Headache The Journal of Head and Face Pain · doi:10.1111/head.70202

The central neurometabolic fingerprint of persistent spinal pain syndrome type 2: A prospective [18F]FDG PET/CT neuroimaging study

Burmeister, L. S., van Grinsven, M., van Roosendaal, B.-K. W. P., Witkam, R. L., Arnts, I., Janssen, S., Wegener, J. T., Vissers, K. C. P., Arens, A. I. J., Gotthard, M., et al. (2026) · Neurobiology of Pain · doi:10.1016/j.ynpai.2026.100235

Usefulness of knockout mice to clarify the role of the opioid system in chronic pain

Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14088 · Cited by 32 · see citing works

Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies

Befort, K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00006 · Cited by 134 · see citing works

Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses

Maldonado, R. J., & Valverde, O. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.001 · Cited by 62 · see citing works

Endocannabinoids in pain modulation

Walker, J. M., & Huang, S. M. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0361 · Cited by 79 · see citing works

Cannabinoids Pain Signaling Pathways

Charipova, K., & Gress, K. L. (2023) · Cambridge University Press eBooks · doi:10.1017/9781108979849.003